| | | | Index Performance | | Index | Sensex | Nifty | | Open | 17,779.54 | 5,285.00 | | High | 17,779.54 | 5,290.80 | | Low | 17,258.20 | 5,098.35 | | Today's Cls | 17,578.72 | 5,223.50 | | Prev Cls | 17,824.48 | 5,285.10 | | Change | -245.76 | -61.60 | | % Change | -1.38 | -1.17 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | CMC | 924.85 | 8.24 | | Aurobindo Pharma | 329.75 | 6.37 | | RPL | 175.20 | 6.18 | | Wyeth | 505.60 | 6.13 | | United Phosphorus | 334.85 | 5.05 | | Losers | | Chambal Fertiliser | 58.50 | -9.51 | | Spice Tele | 34.50 | -5.74 | | Suzlon Energy | 281.30 | -5.67 | | GNFC | 182.10 | -5.43 | | HCL Tech | 277.60 | -4.92 | | | Market Statistics | | - | BSE | NSE | | Advances | 1,067 | 447 | | Declines | 1,630 | 718 | | Unchanged | 46 | 25 | | Volume(Nos) | 36.18cr | 68.13cr | | | | | | Market Commentary | | | Sensex clobbered, drops 246 points | | Across the board selling pressure saw the Sensex shed 246 points to close at 17,579. | | The market crumbled after profit taking set in during the early trades and lingered in the negative territory all through the trading session. | | | | With the major Asian indices not recovering from their yesterday's slump further hurt the market sentiment and aggravated selling pressure in the afternoon trades. Weakness in heavyweight, consumer goods, realty and IT stocks dragged the index to the day's low of 17,258, down 566 points from its last close. The Sensex finally signed off the session with losses of 246 points at 17,579. The Nifty dropped 62 points to close at 5,223. | | | Movers & Shakers | - Dabur Pharma failed to gain inspite of announcing approval and launch of Irinotecan Hydrochloride injection in the United States
| | | | Dragging down the markets, Infosys dropped 3.29% at Rs1,547, Larsen & Toubro tumbled 3.24% at Rs3,523, RIL faltered 3.09% at Rs2,458, DLF slumped 3.08% at Rs781, Tisco shed 2.69% at Rs802, Wipro lost 2.64% at Rs434.65 and ONGC declined 2.58% at Rs1,012.35. However, select blue chip counters managed to clock decent gains. Maruti rose 3.86% at Rs867.20, SBI moved up by 3.48% at Rs2,109.70, Hind Utilities jumped 3.27% at Rs227.35, Bajaj Auto added 2.73% at Rs2,280.15, M&M advanced 1.86% at Rs692.80 and HDFC jumped 1% at Rs2,808.
Except BSE Auto, BSE Bankex, BSE FMCG and BSE HC index, rest of the sectoral indices ended in the red. BSE CG, BSE Realty, BSE IT, BSE Teck, BSE Power and BSE CD index dropped over 2%, while other indices were down around 1% each. However, Auto stocks attracted strong buying support. Ashok Leyland soared 4.17% at Rs37.45, Maruti advanced 3.86% at Rs867, Bajaj Auto scaled 2.73% at Rs2,280 and Hero Honda, M&M, Amtek, Escorts and TVS Motor gained over 0.5-2% each.
Over 3.58 crore Nagarjuna Fertilisers shares changed hands on the BSE followed by RPL (1.92 crore shares), IFCI (1.72 crore shares), Chambal Fertilisers (1.49 crore shares) and RNRL (1.33 crore shares). | | | | | | | | European Indices at 16:15 IST on 29-02-2008 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 5922.00 | -43.70 | -0.73 | | CAC 40 Index | 4821.57 | -43.66 | -0.90 | | DAX Index | 6796.93 | -65.59 | -0.96 | | | | | | | | | | | Asian Indices at close on 29-02-2008 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 13603.02 | 322.49 | -2.32 | | Hang Seng Index | 24331.67 | -260.02 | -1.06 | | Kospi Index | 1711.62 | -24.55 | -1.41 | | Straits Times Index | 3026.45 | -47.70 | -1.55 | | Jakarta Composite Index | 2721.94 | -34.37 | -1.25 | | | | | | | | To know more about our products and services, click here. | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
No comments:
Post a Comment